Extended Abstract Ocular drug delivery systems have the potential to improve drug bioavailability, reducing side effects and facilitating patient adherence by avoiding frequent administration, which is a major noncompliance with many chronic eye disorders as inflammatory process. Several recent studies have shown that nonsteroidal anti-inflammatory drugs are also effective in the treatment or p...

Along with viral vectors, non-viral strategies have been developed in order to efficiently deliver nucleic acids to ocular cells. During the last decade, we have observed that the outcome of these non-viral delivery systems depends on the genetic material used, the targeted tissue or cells, the expected effect duration, and the routes of administration. Assessment of efficiency has been evaluat...